NCT02355145View on ClinicalTrials.gov

Non-inteRvEntional Study to Observe rAtionaLe to Select add-on TherapY for Type 2 Diabetes Inadequately Controlled With Metformin.

CompletedOBSERVATIONAL
Enrollment

1,005

Participants

Timeline

Start Date

April 2, 2015

Primary Completion Date

July 28, 2016

Study Completion Date

July 28, 2016

Conditions
Type 2 Diabetes Mellitus
Trial Locations (3)

Unknown

Research Site, Pleven

Research Site, Sofia

Research Site, Stara Zagora

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY